<DOC>
	<DOCNO>NCT00068237</DOCNO>
	<brief_summary>RATIONALE : Moving salivary gland area undergo radiation therapy may protect gland side effect radiation therapy may prevent xerostomia ( dry mouth ) . PURPOSE : Phase II trial study effectiveness salivary gland surgery prevent xerostomia patient undergo radiation therapy head neck cancer .</brief_summary>
	<brief_title>Salivary Gland Surgery Before Radiation Therapy Preventing Radiation-Caused Xerostomia Patients With Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine reproducibility surgical technique submandibular salivary gland transfer patient head neck cancer . - Determine rate severity radiation-induced xerostomia surgery patient . - Determine pattern recurrence , disease-free survival , overall survival patient treat surgery follow radiotherapy . - Determine quality life patient treat regimen . OUTLINE : This multicenter study . Patients undergo surgical transfer submandibular salivary gland submental space . Within 4-6 week surgery , patient undergo radiotherapy daily , 5 day week 5 ½ 7 week absence disease progression unacceptable toxicity . Salivary scan perform surgery , 2-3 week surgery , 6 month start radiotherapy . Quality life assess baseline 3 , 6 , 12 month start radiotherapy . Patients follow every 3 month 2 year every 6 month 3 year annually . PROJECTED ACCRUAL : A total 11-48 patient accrue study within 1.6 year .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Xerostomia</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : One follow diagnosis : Histologically confirm , previously untreated squamous cell carcinoma oropharynx , hypopharynx , larynx Head neck cancer unknown primary unilateral metastasis neck node No N3 disease No carcinoma oral cavity nasopharynx No bilateral neck node involvement No suspicious neck node contralateral neck side choose salivary gland transfer CT scan MRI No preepiglottic space involvement No involvement level 1 node either side neck No salivary gland malignancy No recurrent disease PATIENT CHARACTERISTICS : Age At least 18 year old Performance status Zubrod 01 Life expectancy Not specify Hematopoietic Hemoglobin least 10 g/dL Hepatic Not specify Renal Not specify Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No salivary gland disease ( e.g. , Sjögren 's syndrome ) No malignancy within past 3 year except basal cell squamous cell skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy More 3 year since prior chemotherapy No prior concurrent neoadjuvant chemotherapy Concurrent adjuvant chemoradiotherapy ( addition study radiotherapy ) allow Endocrine therapy Not specify Radiotherapy See Chemotherapy No prior radiotherapy head neck No concurrent intensitymodulated radiotherapy Surgery Not specify Other No concurrent cholinergic drug No concurrent anticholinergic drug No concurrent tricyclic drug No concurrent prophylactic amifostine pilocarpine least 3 month completion study radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>xerostomia</keyword>
	<keyword>radiation toxicity</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage I squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage II squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
</DOC>